Among several subtypes of breast cancer classified by molecular characteristics, HER2-positive tumors account 15% to 20% of all breast cancers and display more aggressive behaviors and a poorer prognostic clinical course (2). This evidence concerns the gene ERBB2 and breast carcinoma.